Introduction
Thomas Sydenham, the 'English Hippocrates' of the late seventeenth century, was a man of some wit. On being asked why certain diseases lacked mention in his medical texts, his answer was that he did not write about diseases that he was unable to cure. This reply daunts anyone who writes about viruses, especially those associated with slow infections. Here, not only are we unable to cure but, all too often, we are unable to satisfy the criteria laid down by Robert Koch. Why then should these slow infections now make a claim for our attention? The roots of this present interest are widely dispersed. Although the transmissibility of scrapie was described in the 1930s, interest was limited. Until the 1950s, the main stream of animal virology was concerned with the causes of acute disease. In that decade, the bulk of the viruses with which we are now familiar were recognized and handled in the laboratory for the first time. Parallel with these developments came the recognition that viruses could produce malignant transformation in cultured cells and that, in such transformed cells, incomplete viruses and noninfectious viral antigens could be detected.
During the closing years of that decade a veterinary research worker W. J. Hadlow, in a letter to the Lancet in 1959, drew attention to the close resemblance between scrapie and kuru. From this stemmed the flow of original investigation which has now established that some, at least, of the degenerative neurological diseases of man are transmissible.
The term 'slow virus', must not be accepted as one which defines a genuine class. It embraces a number of diverse agents, only united by the chance that they produce diseases with excessively long incubation periods. Nevertheless, with these caveats, the term is of use.
Group A slow infections
This group includes visna and maedi. The first description of visna was by Sigurdsson, Palsson and Grimsson in 1957 (Palsson, 1972 (Gislason, 1947) (Pattison et al., 1972 (Dickinson, 1977 (Dickinson, Fraser and Outram, 1975) .
The other subacute spongiform encephalopathy, TME, closely resembles scrapie. First recognized in 1947 (Barlow, 1972) , it occurs sporadically in mink farms and may be an adapted form of scrapie due to the inclusion of infected meat in the mink diet.
Scrapie and TME have similar host ranges but whereas scrapie can be transmitted to mink producing a disease indistinguishable from TME, the reverse is not true. (Diener, 1974 (Gajdusek and Zigas, 1957) was the earliest one to be widely read. Kuru (Gajdusek, Gibbs and Alpers, 1966 (Manuelidis et al., 1976) and mice (Manuelidis, Gorgacz and Manuelidis, 1978) are susceptible and there has been a solitary report that household cats can also be successfully infected (Gajdusek and Gibbs, 1975 (Gajdusek and Gibbs, 1976 (Townsend et al., 1975) . In most of these there were underlying immunological deficiencies, and in others infection may have occurred in utero.
Other animal models have been developed in which subacute encephalitis occurs following viral infection. Zlotnik, Grant and Batter-Hatton (1972) inoculated mice with an avirulent strain of Semliki Forest virus. After 6 weeks, all signs of histological encephalitis had disappeared but when the mice were killed 2 years later, there was astrocytosis, spongy degeneration and hydrocephalus. Neurological and intellectual impairment have been described, as late sequelae to infection with Venezuelan equine encephalitis, tick-borne encephalitis viruses and with enteroviruses (Sells, Carpenter and Ray, 1975) but it is difficult to be sure whether these do not result entirely from acute damage to an immature central nervous system (CNS). Considering these unusual late sequelae of infection with conventional viruses, one must remember that latent and apparently harmless infections may occur in asymptomatic individuals. Certainly, such infections are well known in primates where some of the viruses which have been recovered are closely related to the RNA tumour viruses, and a type C virus recovered from the gibbon brain is related to the GALV-1 strain, itself a candidate human tumour virus. In man, adenovirus type 7 has been recovered from the brain of a patient in whom there was no evidence of encephalitis (Lord, Sutton and Corsellis, 1975) although this adenovirus itself is probably slightly neurotropic (Sutton et al., 1976 (Yamamoto and Koprowski, 1975 
